Table 1

Anti-MCV, anti-CCP, and IgM-RF antibodies in the control patients according to the diagnosis

Number (percentage) of patients with positive antibodies

Anti-MCV

Anti-CCP

IgM-RF


Cutoff

20 U/mL

Cutoff

28 U/mL


Psoriatic arthritis (n = 51)

6 (11.8)

5 (9.8)

5 (9.8)

5 (9.8)

Primary Sjögren syndrome (n = 58)

6 (10.3)

6 (10.3)

6 (10.3)

15 (25.8)

Ankylosing spondylitis (n = 49)

3 (6.1)

2 (4.1)

1 (2)

1 (2)

Healthy controls (n = 50)

5 (10)

0 (0)

0 (0)

0 (0)

Total (n = 208)

20 (9.6)

13 (6.2)

12 (5.8)

21 (10.1)


Anti-CCP, anti-cyclic citrullinated peptide antibody; anti-MCV, anti-mutated vimentin citrullinated antibody; RF, rheumatoid factor.

Nicaise Roland et al. Arthritis Research & Therapy 2008 10:R142   doi:10.1186/ar2570

Open Data